OUR MISSION:
To partner with healthcare providers, payers, patients and advocacy groups to eradicate colorectal cancer.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

CologuardĀ® Wins Popular Science Magazine's 2014 "Best of What's New" Award

Exact Sciences' new colon cancer screening test recognized as a revolution in healthcare MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced Cologuard has received a 2014 "Best of What's New" award from Popular Science. Cologuard is the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer. Approved by...Read more

Cologuard Included in American Cancer Society Colorectal Cancer Prevention and Early Detection Guidelines

Updated guidelines include recommended use of noninvasive stool-based DNA screening test every three years MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that the American Cancer Society's Colorectal Cancer Prevention and Early Detection national guidelines for colorectal cancer screening now reflect the commercial availability of Cologuard, the...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com

FOR OUR INVESTORS

View updates on upcoming conference appearances, company news, financial reports and more.

Learn More